Evidence map›Paper›PMID 41788146›Full record

ReviewAlpha psychiatry2026

Cognitive Impairment and Non-Invasive Neuromodulation Interventions in Bipolar Disorder: A Narrative Review of Current Status and Future Directions.

Guilan Sun, Tongjie Zhuang, Minmin Wang, Xiaomei Zhang

Abstract readReview
In one paragraph

Review in Alpha psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guilan SunDepartment of Psychiatry, Huzhou Third Municipal Hospital, The Affiliated Hospital of Huzhou University, 313000 Huzhou, Zhejiang, China.
Tongjie ZhuangSchool of Biomedical Engineering and Instrument Science, Zhejiang University, 310007 Hangzhou, Zhejiang, China.ORCID https://orcid.org/0009-0009-3146-8822
Minmin WangSchool of Biomedical Engineering and Instrument Science, Zhejiang University, 310007 Hangzhou, Zhejiang, China.
Xiaomei ZhangDepartment of Psychiatry, Huzhou Third Municipal Hospital, The Affiliated Hospital of Huzhou University, 313000 Huzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bipolar disorder (BD) is a severe mental illness characterized by recurrent episodes of mania and depression. The disorder is associated with high rates of relapse and disability, significantly affecting patients' social functioning and quality of life. It is estimated that 30-50% of individuals with BD do not regain their premorbid level of social functioning, primarily due to persistent cognitive impairments. These cognitive deficits are prominent not only during acute episodes but also persist throughout remission, even when emotional symptoms have stabilized. Multiple studies have demonstrated that cognitive dysfunction is widely recognized as a key predictor of relapse, disease progression, and loss of social functioning in individuals with BD. An increasing body of research suggests that the long-term prognosis of BD is closely linked to cognitive impairment, establishing cognitive remediation as a central therapeutic goal for improving social functioning in this population. However, current pharmacological treatments for cognitive deficits show limited efficacy and are frequently associated with notable side effects. Non-pharmacological approaches, particularly neuromodulation techniques, are increasingly recognized for their potential to improve cognitive deficits in BD. This narrative review summarizes the latest findings on neuromodulation interventions for cognitive impairment in BD, with a focus on the current applications and future directions of non-invasive neuromodulation techniques.

Indexed as

bipolar disordercognitive impairmentneuromodulationnon-invasive

Identifiers

PMID41788146
PMCPMC12957971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.